Results 161 to 170 of about 10,162 (193)

Evaluation of Local and Systemic Melatonin Administration on Bone Healing After Tooth Extraction in Bisphosphonate-Treated Rats. [PDF]

BMC Oral Health
Kulfel CG, Alan HT, Yildiz A, Ozhan O.
europepmc   +1 more source

The role of macrophage migration inhibitory factor (MIF) in the pathogenesis and progression of cardiovascular disease

British Journal of Pharmacology, EarlyView.
Abstract Cardiovascular disease (CVD) remains the leading global cause of death, driven by complex mechanisms, in which chronic inflammation plays a central role. Inflammatory pathways contribute to all stages of CVD, from endothelial dysfunction and plaque formation to erosion, rupture and myocardial injury.
Shreya Mahabhashyam, James Harris, Jürgen Bernhagen, Antony Vinh, Katrina M. Mirabito Colafella   +4 more
wiley   +1 more source

Early Postmenopausal Fragility Fractures and Elevated IgE: Two Cases Suggesting Hyper-IgE Syndrome and a Novel Adverse Reaction to Romosozumab. [PDF]

Calcif Tissue Int
Collins L, Ebeling PR.
europepmc   +1 more source

Plant-derived extracellular vesicles as emerging biotherapeutic agents and delivery vehicles for rheumatoid arthritis: evidence from preclinical models. [PDF]

Front Immunol
Liu Y, Xu X, Zou N, Chen Q, Wu S.
europepmc   +1 more source

Clinical and Genetic Characterization of Osteogenesis Imperfecta in Japanese Patients: Outcomes of Sequential Bisphosphonate Therapy. [PDF]

Calcif Tissue Int
Yamada C, Kubota T, Nakayama H, Ohata Y, Okamura S, Yamamoto K, Fujiwara M, Ozono K, Kitabatake Y.   +8 more
europepmc   +1 more source

Denosumab and bone loss in uncemented total hip arthroplasty: a secondary 5-year follow-up of a randomized controlled trial. [PDF]

Acta Orthop
Sköld C, Hailer NP, Mallmin H.
europepmc   +1 more source

Antifracture Efficacy of 5- or 10-Yearly Zoledronate in Women Aged 50 to 60 Years: Secondary Analyses of a Randomized Trial.

J Clin Endocrinol Metab
Bolland MJ, Nisa Z, Mellar A, Gasteiger C, Pinel V, Mihov B, Bastin S, Grey A, Reid IR, Gamble G, Horne A.   +10 more
europepmc   +1 more source

The impact of DXA findings on general practitioners' decision regarding first-line oral bisphosphonates in postmenopausal osteoporosis-data from French General Practice (the IMOGENE study). [PDF]

Arch Osteoporos
Cortet B, Chelbani L, Garot T, Samama P, Lespessailles E.   +4 more
europepmc   +1 more source

Real-world effectiveness of denosumab compared to teriparatide in patients with severe osteoporosis. [PDF]

Front Endocrinol (Lausanne)
Birtolo MF, Piasentier A, Dutu AD, Vena W, Morenghi E, Pigni S, Gentile LMS, Fanti A, Vitale V, Pucci A, Capo G, Tomei M, Brembilla C, Fornari M, Laghi A, Politi LS, Bossi AC, Lania AGA, Mazziotti G.   +18 more
europepmc   +1 more source

Health and adverse events associated with extended oral bisphosphonates among postmenopausal women: a systematic review.

J Clin Endocrinol Metab
Oka P, Moosa AS, Koh EYL, Ng CJ.
europepmc   +1 more source